Additional Information
Short Description: |
HDAC inhibitor |
Research Area: |
Cell Signaling, Epigenetics and Nuclear Signaling, Cancer |
Alternative Name(s): |
Suberoylanilide-hydroxamic acid; Vorinostat; N-Hydroxy-N'-phenyloctanediamide |
Category: |
Small Molecules |
Product Type: |
Inhibitor |
CAS No.: |
149647-78-9 |
Molecular Formula: |
C14H20N2O3 |
Molecular Weight: |
264,3 |
Source: |
Synthetic |
Purity: |
>98% (TLC), NMR conforms |
Solubility: |
Soluble in 50 mg/ml DMSO, or 2 mg/ml Ethanol |
Appearance: |
White Solid |
Storage: |
-20ºC |
Shipping: |
Shipped Ambient |
SMILES: |
C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO |
InChI: |
InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18) |
InChIKey: |
WAEXFXRVDQXREF-UHFFFAOYSA-N |
Field of Use: |
For in vitro research use only. |
Related Products
SAHA (Vorinostat )
321
NULL140.00 - NULL330.00
SAHA (Vorinostat ) | P004 | Cyclic GMP Standard, 350UL DataSheet
321-P004
Vorinostat (SAHA) | E1KS1047
426
NULL405.00
Vorinostat (SAHA) | E1KS1047 | Gentaur UK, US & Europe Distribution
426-E1KS1047
SAHA | 1604
26
NULL343.00 - NULL707.00
Potent, reversible inhibitor of histone deacetylase 1 (HDAC1) and 3 (HDAC3). Induces cell growth arrest at both G1 and G2 phases. Induces apoptosis.SAHA is a potent, reversible inhibitor of histone...
26-1604-GEN